EWTX logo

Edgewise Therapeutics, Inc. Common Stock


EWTX: Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.


Show EWTX Financials

Consumer Interest
SEC Filings

Recent trades of EWTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by EWTX's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Pyridazinone compounds and uses thereof Jul. 19, 2022
  • Patent Title: Pyridazinone compounds and uses thereof Feb. 01, 2022
  • Patent Title: Pyridazinone compounds and uses thereof Aug. 17, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of EWTX in WallStreetBets Daily Discussion


Recent insights relating to EWTX

CNBC Recommendations

Recent picks made for EWTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EWTX

Corporate Flights

Flights by private jets registered to EWTX